Survivin expression induced by doxorubicin in cholangiocarcinoma

doi:10.3748/wjg.v10.i3.415

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3114)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

351

HTML

2414

Figures (1-3)

174

Tables (1-3)

175

Sum=3114

Feb 1, 2004 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Feb 1, 2004; 10(3): 415-418
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.415

Full Size Figure Download Figure

Figure 2 Expression of survivin in a human cholangiocarcinoma cell line. β-actin served as control. M: DL2000 marker, 1: Normal Qbc939, 2: 24 h after adding doxorubicin, 3: 48 h after adding doxorubicin.

Citation: Chang Q, Liu ZR, Wang DY, Kumar M, Chen YB, Qin RY. Survivin expression induced by doxorubicin in cholangiocarcinoma. World J Gastroenterol 2004; 10(3): 415-418
URL: https://www.wjgnet.com/1007-9327/full/v10/i3/415.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i3.415